#insulin resistance

1 article

A clean, modern editorial flat-lay on a pale oat-colored linen surface, shot from slightly above in soft diffused natural window light. At the center sits an amber glass supplement bottle with a minimalist cream label, unbranded, with a few capsules spilling onto the fabric in soft greens and ivory tones. Around it are fresh botanical elements: a sprig of green tea leaves, sliced ginger root, a small bundle of dried hibiscus petals, and a few pale green pineapple and papaya slices hinting at digestive enzymes. A small ceramic bowl of creamy plain yogurt with a wooden spoon suggests probiotics. To the left, a flexible tailor's measuring tape in soft blush pink loosely curls across the linen, with a slim brushed-brass scale partly visible at the frame edge. On the right, a minimalist white notebook lies open with a hand-drawn simple line chart showing two diverging lines, one trending downward and one flat, with no readable text. A pair of reading glasses with thin gold frames rests beside it, and a tiny pair of balanced brass scales sits in the background, subtly suggesting weighing evidence and caution.

The palette is muted sage green, warm cream, soft terracotta, and touches of blush and brass. Shadows are gentle and long, the depth of field is shallow with a creamy blurred background, and the negative space on the left third of the frame leaves room for a headline overlay. The overall feel is a contemporary health and science journal, calm, trustworthy, and slightly skeptical, in the style of a premium wellness magazine photographed with a 50mm lens, with crisp texture on linen, glass, and botanicals.

Le mélange probiotique‑enzymatique SlimSEB surpasse le placebo — mais attention à un détail

BY DR. GYMBRO · 30 oct. 2026

Un mélange de probiotiques, d’enzymes et de plantes appelé SlimSEB a surpassé le placebo dans un essai randomisé de 12 semaines mené chez 87 adultes à risque de diabète de type 2. Les participants obèses ont perdu 4,5 kg de plus que le groupe placebo et ont réduit leur tour de taille de 11 cm, tandis que le cholestérol et la résistance à l’insuline se sont également améliorés. Cependant, le produit a été fourni par son fabricant, l’étude était petite et courte, et la formule à multiples ingrédients empêche d’attribuer les effets à un composant unique. Voici ce que montrent les données, comment elles se comparent aux médicaments GLP‑1, et à qui il faut rester prudent.